ArticleCancer immunology, immunotherapy : CII2024

Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents.

Dingyi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.